Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA.
Phytother Res. 2010 Sep;24(9):1278-84. doi: 10.1002/ptr.3093.
An ethanolic extract of Artemisia dracunculus L. (PMI 5011) has been observed to decrease glucose and insulin levels in animal models and enhance cellular signaling in cultured cells. To determine the mechanism of action of PMI-5011, we have measured changes in protein expression in human primary skeletal muscle culture (HSMC) from subjects with Type 2 diabetes. After obtaining skeletal muscle biopsies, HSMCs were initiated, grown to confluence, and exposed to 10 microg/mL PMI 5011 overnight. Two-dimensional difference in-gel electrophoresis was used to separate proteins, and liquid chromatography mass spectrometry was used to identify differentially regulated proteins. Additionally, real-time polymerase chain reaction (PCR) was used to confirm candidate proteins identified. These data demonstrate that a well characterized botanical extract of Artemisia dracunculus L. significantly modulates proteins involved in regulating inflammatory pathways, particularly the NFkappaB complex system.
从 2 型糖尿病患者中分离得到的人原代骨骼肌细胞(HSMC),经测定,艾草(PMI 5011)的乙醇提取物能够降低动物模型中的葡萄糖和胰岛素水平,并增强细胞培养中的细胞信号。为了确定 PMI-5011 的作用机制,我们已经测量了人原代骨骼肌细胞(HSMC)中蛋白质表达的变化。获得骨骼肌活检后,启动 HSMC,使其生长至汇合,并将其暴露于 10μg/ml 的 PMI 5011 过夜。二维差异凝胶电泳用于分离蛋白质,液质联用技术用于鉴定差异调节蛋白。此外,实时聚合酶链反应(PCR)用于确认鉴定出的候选蛋白。这些数据表明,一种经过充分特征描述的艾草植物提取物能显著调节参与调节炎症途径的蛋白质,特别是 NFkappaB 复合系统。